Teva Pharmaceutical Industries reported $57M in Ordinary Share Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Amarin AMRN:US $ 292.78M 0.42M
Amgen AMGN:US $ 31877M 71M
Antares Pharma ATRS:US $ 1.7M 0.01M
AstraZeneca AZN:LN 328M 0M
Biogen BIIB:US $ 0.1M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Coherus Biosciences CHRS:US $ 0.01M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Emergent Biosolutions EBS:US $ 0.1M 0M
Endo International Ordinary Shares ENDP:US $ 0.07M 0M
Flexion Therapeutics FLXN:US $ 50K 0
GlaxoSmithKline GSK:LN 1347M 1M
Henry Schein HSIC:US $ 1.4M 0.02M
Horizon Pharma HZNP:US $ 0.02M 0M
Lannett LCI:US $ 0.04M 0M
Novartis NOVN:VX SF 913M 0M
Pacira Pharmaceuticals PCRX:US $ 0.04M 0M
Perrigo Ordinary Shares PRGO:US $ 7081.7M 19.6M
Phibro Animal Health PAHC:US $ 0M 0M
Revance Therapeutics RVNC:US $ 0.07M 0M
Supernus Pharmaceuticals SUPN:US $ 0.05M 0M
Takeda 4502:JP Y 1669125M 980M
Teva Pharmaceutical Industries TEVA:US $ 57M 0M
Xeris Pharmaceuticals Inc XERS:US $ 7K 0
Zoetis ZTS:US $ 5M 0M